Identification | Back Directory | [Name]
N-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite | [CAS]
182495-83-6 | [Synonyms]
DMT-2'-F-dC(Bz)-CE-Phosphoramidite 2’-Fluoro-5MeC (Bz)-3’-phosphoramidite N-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxy-2’-fluoro-5-methylcytidine-3’-O-[(2-cyanoethyl) (N,N-diisopropyl)]phosphoramidite Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-5-methyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) 2’-Fluoro-5MeC(Bz)-3’-phosphoramidite,N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxy-2’-fluoro-5-methylcytidine-3’-O-[(2-cyanoethyl) ,(N,N-diisopropyl)]phosphoramidite | [Molecular Formula]
C47H53FN5O8P | [MDL Number]
MFCD34548945 | [MOL File]
182495-83-6.mol | [Molecular Weight]
865.94 |
Hazard Information | Back Directory | [Uses]
DMT-2'-F-dC(Bz)-CE-Phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Website: |
m.is0513.com/showsupplierproductslist1701258/0.htm |
Company Name: |
Pharmalego
|
Tel: |
021-02158596539 18321033991 |
Website: |
cn.pharmalego.com/ |
|